G pharmaceutical composition for preventing, treating or delaying the Alzheimer's disease or dementia containing protein-coupled receptor 19 agonist as an active ingredient

The present invention is G protein-coupled receptor 19 (G protein-Coupled Receptor19, GPCR19) agonist or to a pharmaceutically Alzheimer's disease containing acceptable salts as an active ingredient (Alzheimer Disease, AD) or the prevention of dementia, treatment or delay as a pharmaceutical composition, and Alzheimer's disease or dementia, for prevention, improvement, or on a food composition for delaying, G protein-coupled receptor 19 agonist according to the present invention, when administered to a subject does not harm the health of the individual, cognitive disorders and show the efficacy of improving the behavioral disorder, inhibit the apoptosis of brain tissue, enhancing the immune system and, amyloid-β plaque by reducing the formation prevention of Alzheimer's disease or dementia, or of, slow the progression of disease in the object is already diseases caused may indicate that the effectiveness increase or treatment.